secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuroPace Inc (NPCE)
CIK:        0001528287
Form:       8-K
Filed at:   2023-06-28T23:59:59+00:00
Accession:  0001193125-23-177492
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroPace CEO Michael Favet resigns; Joel Becker appointed as new CEO effective July 10, 2023
--------------------------------------------------------------------------------

- Michael Favet resigns as CEO and Board member effective July 10, 2023; will provide consulting services for 12 months at $600/hour.
- Joel Becker appointed President and CEO effective July 10, 2023; also joins Board as Class I director through 2025 annual meeting.
- Becker receives base salary of $520,000/year, target bonus of 75% of salary, and option grant of 380,424 shares vesting over 4 years.
- Becker most recently served as President at Viking North Ventures; prior roles include Integer Holdings and St. Jude Medical.
- Favet's unvested equity awards will be cancelled on August 1, 2023; vested options remain exercisable per award agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/0001193125-23-177492-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528287/000119312523177492/d506395d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-177492

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer